Biotech · Private company · Belchertown, MA, US
Regene LLC
Track this companyFree. Adds Regene LLC to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards2
- Targeting Type 3 Diabetes (T3D) Mechanism of Alzheimer's Disease (AD) and AD-Related DementiasFiscal year 2025 · $250KNIH RePORTER 5R43AG085738-02 · fetched Nov 12, 2026
- Targeting Type 3 Diabetes (T3D) Mechanism of Alzheimer's Disease (AD) and AD-Related DementiasFiscal year 2024 · $250KNIH RePORTER 1R43AG085738-01 · fetched Nov 12, 2026